These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5230288)

  • 21. [Mechanism of action of diuretics of the anti-aldosterone type].
    Rorive GL
    Acta Cardiol; 1973; ():Suppl 17:291-3. PubMed ID: 4543701
    [No Abstract]   [Full Text] [Related]  

  • 22. [Influence of triamterene, aldactone and amilorid on the electrolyte excretion following oral potassium loading test in rats].
    Formanek K; Hohenegger M
    Wien Klin Wochenschr; 1970 Mar; 82(13):240-1. PubMed ID: 5419661
    [No Abstract]   [Full Text] [Related]  

  • 23. Potassium-sparing diuretics.
    Horisberger JD; Giebisch G
    Ren Physiol; 1987; 10(3-4):198-220. PubMed ID: 2455308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diuresis and diuretics].
    Schmidt P
    Wien Klin Wochenschr; 1971 Jun; 83(25):456-9. PubMed ID: 5130897
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of aldosterone and spirolactone on urinary sodium and potassium excretion in newborns and infants (author's transl)].
    Solc J; Knorr D
    Z Kinderheilkd; 1974 Jan; 116(2):143-52. PubMed ID: 4816159
    [No Abstract]   [Full Text] [Related]  

  • 26. [Renal effects of aldosterone and spironolactone in rats f different age].
    Bräunlich H; Kersten L
    Acta Biol Med Ger; 1972; 28(1):73-80. PubMed ID: 5048187
    [No Abstract]   [Full Text] [Related]  

  • 27. High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronism.
    Radó JP; Marosi J; Takó J
    Endokrinologie; 1970; 57(1):46-62. PubMed ID: 4923990
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effects of potassium chloride and triamterene on kaliuresis, natriuresis and diuresis in congestive heart failure].
    Kabakov AI; Zharov EI
    Klin Med (Mosk); 1995; 73(5):33-5. PubMed ID: 8815272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [TREATMENT OF STATES OF HYPERALDOSTERONISM. THERAPEUTIC INDICATIONS OF SPIRONOLACTONE].
    GUILLEMAN P
    Rev Prat; 1963 Sep; 13():2962-75. PubMed ID: 14091690
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmacology of potassium-sparing diuretics].
    Dominiak P
    Praxis (Bern 1994); 1997 Apr; 86(14):552-5. PubMed ID: 9198848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of diuretics and non-steroidal anti-inflammatory drugs in man.
    Favre L; Glasson P; Riondel A; Vallotton MB
    Clin Sci (Lond); 1983 Apr; 64(4):407-15. PubMed ID: 6337769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diuresis therapy in hyperaldosteronism].
    Wallnöfer H; Hanusch M
    Wien Med Wochenschr; 1966 Dec; 116(52):1159-64. PubMed ID: 5996768
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of saluretics and spironolactone on aldosterone production and electrolyte excretion in man.
    Erbler HC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 286(2):145-56. PubMed ID: 4281879
    [No Abstract]   [Full Text] [Related]  

  • 34. [New clinical application of spironolactone].
    Fukuchi S
    Nihon Rinsho; 1974 Nov; 32(11):3326-32. PubMed ID: 4615183
    [No Abstract]   [Full Text] [Related]  

  • 35. The physiopathologic basis and limitations of treatment of cirrhotic edema with diuretics retaining potassium.
    Vesin P
    Mater Med Pol; 1974; 6(3):199-201. PubMed ID: 4444335
    [No Abstract]   [Full Text] [Related]  

  • 36. [Modification of ionic balance by an injectable antialdosterone drug in resuscitation].
    Roquefeuil B; Nord D; Viguie E; Fischbach C
    Agressologie; 1972; 13(3):185-94. PubMed ID: 5086033
    [No Abstract]   [Full Text] [Related]  

  • 37. The renal regulation of sodium and potassium in patients with chronic renal failure (CRF) and the effect of diuretics on the excretion of these ions.
    Kleeman CR; Okun R; Heller RJ
    Ann N Y Acad Sci; 1966 Nov; 139(2):520-39. PubMed ID: 5230293
    [No Abstract]   [Full Text] [Related]  

  • 38. The diuretic and natruretic activity of triamterene and several related pteridines in the rat.
    Wiebelhaus VD; Weinstock J; Maass AB; Brennan FT; Sosnowski G; Larsen T
    J Pharmacol Exp Ther; 1965 Sep; 149(3):397-403. PubMed ID: 5848050
    [No Abstract]   [Full Text] [Related]  

  • 39. Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance.
    Ma J; Albornoz F; Yu C; Byrne DW; Vaughan DE; Brown NJ
    Hypertension; 2005 Aug; 46(2):313-20. PubMed ID: 15998706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary aldosteronism: effects of inhibition of ACTH and potassium administration on plasma aldosterone concentration.
    Ganguly A; Luetscher JA; Weinberger MH
    Clin Exp Hypertens A; 1982; 4(9-10):1695-714. PubMed ID: 6291813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.